97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01772615 (ClinicalTrials.gov)	May 2011	17/1/2013	Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle	Active Ulcerative Colitis; Placebo Controlled Treatment Trial With Ciprofloxacin and E. Coli Nissle	Ulcerative Colitis	Drug: Ciprofloxacin;Dietary Supplement: E. coli Nissle	Hvidovre University Hospital	NULL	Completed	18 Years	N/A	Both	100	Phase 4	Denmark
2	NCT00355602 (ClinicalTrials.gov)	July 2006	21/7/2006	Antibiotics for the Treatment of Ulcerative Colitis	Use of Antibiotics to Eradicate Bacterial Pathogens Colonising the Colonic Mucosa in Ulcerative Colitis Patients	Colitis, Ulcerative	Drug: Cefuroxime;Drug: Ciprofloxacin;Drug: Clarithromycin;Drug: Cotrimoxazole;Drug: Coamoxiclav;Drug: metronidazole;Drug: neomycin;Drug: rifaximin;Drug: Vancomycin;Drug: Doxycycline	University of Dundee	Tenovus Scotland	Completed	18 Years	79 Years	Both	40	N/A	United Kingdom